$42,106,159

Department of Health and Human Services·National Institutes of Health

ACTION DATE2026-04-09·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75N91020F00021_7529_75N91019D00024_7529

Award description

CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Funds molecular characterization of clinical trial specimens for childhood cancer research through the NIH-led data initiative.

Sub-sectors

nih-research-grantscancer-researchclinical-genomics

Why this matters

Accelerates precision medicine for pediatric cancers by enabling large-scale genomic analysis of tumor specimens to improve treatment outcomes.

Supply-chain signal

Drives demand for genomic sequencing services, bioinformatics platforms, and laboratory automation from biotech service providers.

U.S.–China competition angle

Strengthens U.S. leadership in pediatric cancer genomics and precision medicine, areas where China is rapidly expanding research capacity.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002201.

Period of performance

Start

2020-09-25

End

2030-08-31

Status

activein 1568 days

Recipient

Other awards from this recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75N91020F00021_7529_75N91019D00024_7529.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.